C07K 14/4733
Acute pancreatitis-associated protein
Official title: {Acute pancreatitis-associated protein}
C07K14/4733 (Acute pancreatitis-associated protein) appears on 26 US grants and 30 published applications in this corpus.
Search patents in C07K- Granted patents
- 26
- Published applications
- 30
- Assignees
- 21
- Inventors
- 31
- Latest grant
- 27 Dec 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 3 | 2 |
| 2009 | 0 | 1 |
| 2010 | 2 | 3 |
| 2011 | 3 | 3 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 2 | 0 |
| 2015 | 0 | 3 |
| 2016 | 1 | 2 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 2 |
| 2020 | 1 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Use of peptide compounds in treating acute pancreatitis27 Dec 2022US 11,534,477 B2Shenzhen HighTide Biopharmaceutical, Ltd.
- Compositions and methods of using islet neogenesis peptides and analogs thereof26 Jan 2021US 10,899,815 B2Shenzhen HighTide Biopharmaceutical, Ltd.
- Use of peptide compounds in treating acute pancreatitis15 Sep 2020US 10,772,929 B2Shenzhen HighTide Biopharmaceutical, Ltd.
- Compositions and methods of using islet neogenesis peptides and analogs thereof22 Aug 2017US 9,738,695 B2Shenzhen HighTide Biopharmaceutical, Ltd.
- Compositions and methods of using islet neogenesis peptides and analogs thereof12 Jul 2016US 9,388,215 B2Shenzhen HighTide Biopharmaceutical, Ltd.
- Compositions and methods of using islet neogenesis peptides and analogs thereof3 Nov 2022US 2022/0348618 A1Shenzhen HighTide Biopharmaceutical, Ltd.
- Use of peptide compounds in treating acute pancreatitis8 Apr 2021US 2021/0100871 A1Shenzhen HighTide Biopharmaceutical, Ltd.
- Compositions and methods of using islet neogenesis peptides and analogs thereof5 Nov 2020US 2020/0347106 A1Shenzhen HighTide Biopharmaceutical, Ltd.
- Use of peptide compounds in treating acute pancreatitis18 Jul 2019US 2019/0216883 A1Shenzhen HighTide Biopharmaceutical, Ltd.
- Compositions and methods of using islet neogenesis peptides and analogs thereof24 Jan 2019US 2019/0023755 A1Shenzhen HighTide Biopharmaceutical, Ltd.
Most cited
By later US patents
- Ingap protein involved in pancreatic islet neogenesis40US 5,834,590 AEastern Virginia Medical School of the Medical College of Hampton Roads · 1998
- Protein associated with acute pancreatitis agents for the screening of acute pancreatitis22US 5,436,169 AInstitut National de la Sante et de la Recherche Medicale · 1995
- Compositions and methods of using proislet peptides and analogs thereof22US 8,816,047 B2Cure DM Group Holdings, LLC · 2014
- Ingap protein involved in pancreatic islet neogenesis16US 5,840,531 AEastern Virginia Medical School of the Medicine College of Hampton Roads · 1998
- Peptides, derivatives and analogs thereof, and methods of using same14US 7,393,919 B2Cure DM, Inc. · 2008